“Mission COVID Suraksha” a 3000 crore set up by the government
By Jahanbee Gupta
This mission will be under the whole surveillance of the department of biotechnology, it will concentrate on the tip to toe vaccine development from the clinical trial stage to manufacturing, sources added. To foster the manufacture of vaccines in the country this step is a booster.
Hence, to make sure that a continuous supply of vaccines is there in the country in the coming 12-15 months, there is a necessity to endeavour this project into a much productive and efficient mode. To speed up the manufacturing of out of danger and efficient COVID-19 vaccines in India that can be in reach to all citizens of this country, “Mission COVID Suraksha” has been in the pipeline of worth 3000 crores, sources said.
If we talk with reference to the draft then this mission is emerging as apart of “Aatma Nirbhar Bharat”. It will not only serve the country but will be in service for the whole world as it is working to present a secure and affordable method of protection against the deadly COVID-19.
It will also aid the numerous manufacturing units and confirm the vaccine development and its acceptance by the national immunisation programme. This mission also aims to develop clinical trial sites, immunoassay labs and other hi-tech facilities for the citizens of the country. This proposal will work on the number of vaccines produced to tackle the huge public requirement, but only after the approval of NTAGI, to fight the further spread of this virus.